Overview

A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess whether there is any pharmacokinetic interactions between CAZ-AVI and metronidazole.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Pfizer
Collaborator:
Forest Laboratories
Treatments:
Avibactam
Ceftazidime
Metronidazole